Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Southern Copper Corp (SCCO) vs GeneDx Holdings Corp (WGS) Price & Performance

Southern Copper CorpTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Southern Copper Corp vs GeneDx Holdings Corp — how do they compare? Southern Copper Corp trades at $209.14 (market cap $167.74B), while GeneDx Holdings Corp trades at $67.29 (market cap $2.02B). The key difference: Southern Copper Corp is far larger — about 83× GeneDx Holdings Corp's market cap, and Southern Copper Corp pays a 2.21% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Southern Copper Corp for 61 Days and GeneDx Holdings Corp for 19 Days on average.

SCCOWGS
Market Cap
$167.74B$2.02B
Volume
853,110734,640
Sector
Basic MaterialsHealth
52-Week High
$219.70$167.51
52-Week Low
$120.02$34.51
Typical Hold Time
61 Days19 Days
Enterprise Value
$169.03B$2.05B
Dividend Yield
2.21%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Southern Copper Corp

Southern Copper (SCCO) trades at $208.31, up 3.86% over the past day, but remains below the consensus price target of $167.67. The stock shows strong fundamentals with revenue rising to $13.42B in 2025 and net income reaching $4.33B, though valuation ratios like a P/E of 29.81 and P/S of 10.72 appear elevated. Recent earnings beats and a bullish long-term growth outlook from projects like the $10.2B Mexican pipeline contrast with a bearish technical signal and mixed analyst sentiment.

SCCO presents a cautious outlook due to high valuations and bearish technicals, but robust profitability and expansion projects offer growth potential. Key risks include reliance on copper prices and competitive pressures, while institutional activity shows divided interest. Investors should weigh strong cash flows against premium pricing before entry.

GeneDx Holdings Corp

GeneDx (WGS) trades at $68.09, down 0.64% today, with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue beating expectations but negative profitability metrics, including a -23.4% net income margin. Recent news highlights product launches and industry recognition, while analyst consensus remains strongly bullish with a $81 price target.

The stock presents a growth opportunity in genomic testing with strong analyst support, but faces significant execution risks from persistent losses and high valuation multiples. Key catalysts include continued revenue growth and path to profitability, while risks include competitive pressures and cash flow challenges from negative operating cash flow in 2026.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SCCO
14% Buy86% Sell
Avg holding period · 61 Days
WGS
100% Buy0% Sell
Avg holding period · 19 Days

About Southern Copper Corp

Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.

Read more on SCCO →

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS →